There are also examples of “double hit” or “triple hit” DLBCL which are characterized by co-occurrence of mutations leading to activation of BCL2 with MYC and/or BCL6, and these are associated with a particularly poor outcome [8]. Here, BCL2 is linked to diffuse large B-cell lymphoma.